207 related articles for article (PubMed ID: 35027368)
1. SV2A PET Imaging Is a Noninvasive Marker for the Detection of Spinal Damage in Experimental Models of Spinal Cord Injury.
Bertoglio D; Halloin N; Lombaerde S; Jankovski A; Verhaeghe J; Nicaise C; Staelens S
J Nucl Med; 2022 Aug; 63(8):1245-1251. PubMed ID: 35027368
[TBL] [Abstract][Full Text] [Related]
2. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.
Bertoglio D; Verhaeghe J; Wyffels L; Miranda A; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Bard J; Liu L; Munoz-Sanjuan I; Staelens S
J Nucl Med; 2022 Jun; 63(6):942-947. PubMed ID: 34531262
[TBL] [Abstract][Full Text] [Related]
3. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM
J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
Delva A; Van Laere K; Vandenberghe W
Mov Disord; 2023 Aug; 38(8):1515-1526. PubMed ID: 37382295
[TBL] [Abstract][Full Text] [Related]
7. Potential of [
Puuvuori E; Rokka J; Carlsson PO; Li Z; Eriksson J; Eriksson O
Sci Rep; 2021 Dec; 11(1):24466. PubMed ID: 34963683
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo evaluation of [
Li S; Cai Z; Zhang W; Holden D; Lin SF; Finnema SJ; Shirali A; Ropchan J; Carre S; Mercier J; Carson RE; Nabulsi N; Huang Y
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1952-1965. PubMed ID: 31175396
[TBL] [Abstract][Full Text] [Related]
9. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
[TBL] [Abstract][Full Text] [Related]
10. Preclinical PET Studies of [
Thomsen MB; Schacht AC; Alstrup AKO; Jacobsen J; Lillethorup TP; Bærentzen SL; Noer O; Orlowski D; Elfving B; Müller HK; Brooks DJ; Landau AM
Mol Imaging Biol; 2020 Oct; 22(5):1290-1300. PubMed ID: 32514885
[TBL] [Abstract][Full Text] [Related]
11. Validation and noninvasive kinetic modeling of [
Bertoglio D; Verhaeghe J; Miranda A; Kertesz I; Cybulska K; Korat Š; Wyffels L; Stroobants S; Mrzljak L; Dominguez C; Liu L; Skinbjerg M; Munoz-Sanjuan I; Staelens S
J Cereb Blood Flow Metab; 2020 Jun; 40(6):1351-1362. PubMed ID: 31307287
[TBL] [Abstract][Full Text] [Related]
12. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [
Vogler L; Ballweg A; Bohr B; Briel N; Wind K; Antons M; Kunze LH; Gnörich J; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Boening G; Ziegler SI; Levin J; Zwergal A; Höglinger GU; Herms J; Brendel M
Neuroimage Clin; 2023; 39():103484. PubMed ID: 37541098
[TBL] [Abstract][Full Text] [Related]
13. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of imaging synaptic density in the human spinal cord using [
Rossano S; Toyonaga T; Bini J; Nabulsi N; Ropchan J; Cai Z; Huang Y; Carson RE
EJNMMI Phys; 2022 May; 9(1):32. PubMed ID: 35503134
[TBL] [Abstract][Full Text] [Related]
15. Identification of pre-synaptic density networks using [
Akkermans J; Zajicek F; Miranda A; Adhikari MH; Bertoglio D
Neuroimage; 2022 Dec; 264():119771. PubMed ID: 36436710
[TBL] [Abstract][Full Text] [Related]
16. Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [
Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
EJNMMI Res; 2020 Nov; 10(1):140. PubMed ID: 33185747
[TBL] [Abstract][Full Text] [Related]
17. Exploring with [
Serrano ME; Bahri MA; Becker G; Seret A; Germonpré C; Lemaire C; Giacomelli F; Mievis F; Luxen A; Salmon E; Rogister B; Raedt R; Plenevaux A
Mol Imaging Biol; 2020 Oct; 22(5):1197-1207. PubMed ID: 32206990
[TBL] [Abstract][Full Text] [Related]
18. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [
Zheng C; Holden D; Zheng MQ; Pracitto R; Wilcox KC; Lindemann M; Felchner Z; Zhang L; Tong J; Fowles K; Finnema SJ; Nabulsi N; Carson RE; Huang Y; Cai Z
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284
[TBL] [Abstract][Full Text] [Related]
19. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J
Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839
[TBL] [Abstract][Full Text] [Related]
20. Imaging of Synaptic Density in Neurodegenerative Disorders.
Carson RE; Naganawa M; Toyonaga T; Koohsari S; Yang Y; Chen MK; Matuskey D; Finnema SJ
J Nucl Med; 2022 Jun; 63(Suppl 1):60S-67S. PubMed ID: 35649655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
